195 related articles for article (PubMed ID: 28220037)
21. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma.
Peiró G; Diebold J; Mayr D; Baretton GB; Kimmig R; Schmidt M; Löhrs U
Mod Pathol; 2001 Aug; 14(8):777-83. PubMed ID: 11504837
[TBL] [Abstract][Full Text] [Related]
23. [Characteristic and clinical significance of microRNA expression between 144 Uygur and Han women with endometrial carcinoma].
Wang X; He D; Li WT; Adila S; Han R; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):570-577. PubMed ID: 32541994
[TBL] [Abstract][Full Text] [Related]
24. Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.
Yasue A; Hasegawa K; Udagawa Y
Hum Cell; 2011 Jun; 24(2):65-73. PubMed ID: 21547354
[TBL] [Abstract][Full Text] [Related]
25. Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas.
Akiyama-Abe A; Minaguchi T; Nakamura Y; Michikami H; Shikama A; Nakao S; Sakurai M; Ochi H; Onuki M; Matsumoto K; Satoh T; Oki A; Yoshikawa H
Br J Cancer; 2013 Sep; 109(6):1703-10. PubMed ID: 23949151
[TBL] [Abstract][Full Text] [Related]
26. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
Xu B; Yao Q; Dai SZ
Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
[TBL] [Abstract][Full Text] [Related]
27. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
[TBL] [Abstract][Full Text] [Related]
28. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
[TBL] [Abstract][Full Text] [Related]
29. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
[TBL] [Abstract][Full Text] [Related]
30. Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia.
Orbo A; Nilsen MN; Arnes MS; Pettersen I; Larsen K
Int J Gynecol Pathol; 2003 Apr; 22(2):141-8. PubMed ID: 12649668
[TBL] [Abstract][Full Text] [Related]
31. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma.
Kosmas K; Mitropoulou G; Provatas I; Stamoulas M; Marouga A
Cytopathology; 2018 Dec; 29(6):558-564. PubMed ID: 30007089
[TBL] [Abstract][Full Text] [Related]
32. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
33. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis.
Martini M; Ciccarone M; Garganese G; Maggiore C; Evangelista A; Rahimi S; Zannoni G; Vittori G; Larocca LM
Int J Cancer; 2002 Dec; 102(4):398-406. PubMed ID: 12402310
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
[TBL] [Abstract][Full Text] [Related]
35. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
38. [Expression of DNA mismatch repair protein in endometrial carcinomas and its correlation with clinicopathologic features].
Bi R; Tu XY; Xiao YX; Shan BE; Wang HY; Cai X; Zhou XY; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):302-7. PubMed ID: 27142910
[TBL] [Abstract][Full Text] [Related]
39. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
[TBL] [Abstract][Full Text] [Related]
40. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
